Africa IVD Market by Product & Solution, Technology (Immunoassay, Point of Care, Molecular Diagnostics, Coagulation), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoC), End User - Forecast to 2030

Africa IVD Market by Product & Solution, Technology (Immunoassay, Point of Care, Molecular Diagnostics, Coagulation), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoC), End User - Forecast to 2030


Africa In Vitro Diagnostics Market by Product & Solution, Technology (Immunoassay, Point of Care, Molecular Diagnostics, Coagulation), Application (Infectious Diseases, Diabetes, Oncology), Diagnostic Approach (Lab, OTC, PoC), End User — Forecast to 2030

The Africa IVD market is expected to grow at a CAGR of 2.8% from 2023 to 2030 to reach $1.49 billion by 2030.

After a comprehensive secondary and primary research study and an in-depth analysis of the market scenario, the report provides the key drivers, restraints, challenges, and opportunities in the Africa IVD market.

The high prevalence of infectious diseases, the rising burden of chronic diseases, the rising initiatives to support the healthcare sector, and the growing awareness about the importance of early disease diagnosis are the major drivers for the Africa IVD market. However, poor healthcare facilities and infrastructure in African countries are the major challenges to the market’s growth.

Based on product category, in 2023, the reagents & kits segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the frequent use of assays & kits in the detection of various chronic diseases coupled with the high burden of infectious diseases in African countries.

Based on technology, in 2023, the molecular diagnostics segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to its advantages such as high sensitivity and accuracy, high throughput capability, and the rising prevalence of infectious diseases.

Based on application, in 2023, the infectious diseases segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is primarily attributed to the high prevalence of infectious diseases such as COVID-19, dengue, HIV, and Chagas disease in the region and the rising initiatives to boost testing capabilities.

Based on diagnostic approach, in 2023, the lab testing segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the availability of several IVD tests and the higher accuracy offered by laboratory testing.

Based on end user, in 2023, the hospitals & clinics segment is expected to account for the largest share of the Africa IVD market. The large market share of this segment is attributed to the high demand for IVD diagnostics and the higher preference for hospitals as the primary center of care.

Based on geography, in 2023, South Africa is expected to account for the largest share of this market. The major share of this region is mainly attributed to the high burden of diseases, the rising geriatric population, the increasing initiatives to promote diagnostic testing, and continuous efforts to develop healthcare infrastructure and promote awareness.

The key companies operating in the Africa IVD market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Illumina, Inc. (U.S.), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China).

Scope of the Report

Africa IVD Market Assessment–by Product Category


Reagents & Kits
Instruments
Software & Services

Africa IVD Market Assessment–by Technology

Molecular Diagnostics
Point-of-care Diagnostics
Immunoassay/Immunochemistry
Biochemistry/Clinical Chemistry
Whole Blood Glucose Monitoring
Hematology
Microbiology
Coagulation & Hemostasis
Other IVD Technologies

Note: Other technologies include urinalysis, hybridization, and loop-mediated amplification.

Africa IVD Market Assessment–by Application


Infectious Diseases
Oncology
Diabetes
Cardiology
Nephrology
Autoimmune Disorders
Other Applications

Note: Other applications include toxicology, gastroenterology, neonatal, genetic, and neurological disorders.

Africa IVD Market Assessment–by Diagnostic Approach


Lab Testing
Point-of-care Testing
OTC/Self-testing

Africa IVD Market Assessment–by End User

Hospitals & Clinics
Diagnostic Laboratories
Home Care
Other End Users

Note: Other end users include long-term care facilities, academic & research institutes, ambulatory care centers, and transfusion laboratories.

Africa IVD Market Assessment–by Country


South Africa
Egypt
Algeria
Nigeria
Morocco
Kenya
Tunisia
Tanzania
Rest of Africa

Africa In Vitro Diagnostics Market - Global Opportunity Analysis and Industry Forecast (2023–2030) - Report Summary
Report MetricsDetails
Years Considered2021 - 2030
Base Year2022
Forecast Period2023-2030
Page Count174
Units ReferencedValue (USD Million)
Segments/Key TopicsMarket by Product Category, Technology, Application, Diagnostic Approach, and End User
Regions CoveredSouth Africa, Egypt, Algeria, Nigeria, Morocco, Kenya, Tunisia, Tanzania, and Rest of Africa
Key Companies MentionedAbbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Illumina, Inc. (U.S.), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China).


FAQs About the Report

What is the focus of the Africa IVD market report?


The Africa IVD market report covers the market size & forecasts of various IVD products (reagents & kits, instruments, and software & services) offered by key market players based on various technologies such as immunoassay/immunochemistry, whole blood glucose monitoring, molecular diagnostics, point-of-care diagnostics, biochemistry/clinical chemistry, microbiology, hematology, coagulation & hemostasis, and other IVD technologies.

These IVD products are used for various applications, including infectious diseases, diabetes, oncology, cardiology, nephrology, autoimmune diseases, and other applications. The Africa IVD market study covers various IVD products used for lab testing, OTC/self-testing, and point-of-care testing in diagnostic laboratories, hospitals & clinics, home healthcare, and other end users.

What is the revenue generated from IVD products across Africa? At what rate is their demand expected to grow for the next 5–7 years?

The Africa IVD market is projected to reach $1.49 billion by 2030, at a CAGR of 2.8% during the forecast period.

Which product category is estimated to hold the major share of the market?

Based on product category, in 2023, the reagents & kits segment is expected to account for the largest share of the Africa IVD market.

Which technology segment is estimated to hold the major share of the market?

Based on technology, in 2023, the molecular diagnostics segment is expected to account for the largest share of the Africa IVD market.

Which application segment is projected to create more traction in the Africa IVD market?

Based on application, the cardiology segment is slated to register the fastest growth rate during the forecast period.

Which end user segment is estimated to hold the major share of the market?

Based on end user, in 2023, the hospitals & clinics testing segment is expected to account for the largest share of the Africa IVD market.

What are the key factors supporting the growth of this market?

The high prevalence of infectious diseases, the rising burden of chronic diseases, the increasing initiatives to support the healthcare sector, and the growing awareness about the importance of early disease diagnosis are the key factors driving the growth of the Africa IVD market.

Who are the major players operating in the Africa IVD Market?

The key companies operating in the Africa IVD market are Abbott Laboratories (U.S.), Becton, Dickinson and Company (U.S.), bioMérieux SA (France), Danaher Corporation (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), Siemens Healthineers AG (Germany), Thermo Fisher Scientific Inc. (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Illumina, Inc. (U.S.), and Shenzhen Mindray Bio-Medical Electronics Co., Ltd (China).


1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Process
2.2. Process of Data Collection & Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders from the Industry
2.3. Market Assessment
2.3.1. Market Size Estimation
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study
3. Executive Summary
4. Market Dynamics
4.1. Market Overview
4.2. Drivers
4.2.1. Government Initiatives Supporting Africa’s Healthcare Sector
4.2.2. Rising Prevalence of Communicable and Non-communicable Diseases
4.2.3. Key Market Players’ Increasing Investments in Africa’s IVD Sector
4.3. Restraints
4.3.1. High Prices of IVD Products
4.4. Opportunities
4.4.1. Increasing Awareness Regarding the Importance of Early Diagnosis
4.5. Challenges
4.5.1. Uneven Access To Healthcare
4.5.2. Shortage of Trained Healthcare Personnel
5. Africa IVD Market Assessment–by Product Category
5.1. Overview
5.2. Reagents & Kits
5.3. Instruments
5.4. Software & Services
6. Africa IVD Market Assessment–by Technology
6.1. Overview
6.2. Molecular Diagnostics
6.3. Point-Of-Care Diagnostics
6.4. Immunoassay/Immunochemistry
6.5. Biochemistry/Clinical Chemistry
6.6. Whole Blood Glucose Monitoring
6.7. Hematology
6.8. Microbiology
6.9. Coagulation & Hemostasis
6.10. Other IVD Technologies
7. Africa IVD Market Assessment–by Application
7.1. Overview
7.2. Infectious Diseases
7.3. Oncology
7.4. Diabetes
7.5. Cardiology
7.6. Nephrology
7.7. Autoimmune Disorders
7.8. Other Applications
8. Africa IVD Market Assessment–by Diagnostic Approach
8.1. Overview
8.2. Lab Testing
8.3. Point-of-care Testing
8.4. OTC/Self-Testing
9. Africa In Vitro Diagnostics Market Assessment—by End User
9.1. Overview
9.2. Hospitals & Clinics
9.3. Diagnostic Laboratories
9.4. Home Healthcare
9.5. Other End Users
10. Africa IVD Market Assessment–by Geography
10.1. Overview
10.2. South Africa
10.3. Egypt
10.4. Algeria
10.5. Nigeria
10.6. Morocco
10.7. Kenya
10.8. Tunisia
10.9. Tanzania
10.10. Rest of Africa
11. Competitive Analysis
11.1. Overview
11.2. Key Growth Strategies
11.3. Market Share Analysis (2022)
11.3.1. F. Hoffmann-La Roche Ltd (Switzerland)
11.3.2. Abbott Laboratories (U.S.)
11.3.3. Danaher Corporation (U.S.)
12. Company Profiles (Company Overview, SWOT Analysis for the Top 5 Companies, Financial Overview, Product Portfolio, and Strategic Developments)
12.1. Abbott Laboratories
12.2. Becton, Dickinson and Company
12.3. bioMérieux SA
12.4. Danaher Corporation
12.5. F. Hoffmann-La Roche Ltd.
12.6. QIAGEN N.V.
12.7. Siemens Healthineers AG (A Subsidiary of Siemens AG)
12.8. Thermo Fisher Scientific, Inc.
12.9. Bio-Rad Laboratories, Inc.
12.10. Illumina, Inc.
12.11. Shenzhen Mindray Bio-Medical Electronics Co., Ltd
13. Appendix
13.1. Available Customization
13.2. Related Reports
List of Tables
Table 1 Africa: Rural Population as a Percentage of the Total Population, by Country, 2021
Table 2 Africa IVD Market, by Product Category, 2021–2030 (USD Million)
Table 3 Africa IVD Market for Reagents & Kits, by Country/Region, 2021–2030 (USD Million)
Table 4 Africa IVD Market for Instruments, by Country/Region, 2021–2030 (USD Million)
Table 5 Africa IVD Market for Software & Services, by Country/Region, 2021–2030 (USD Million)
Table 6 Africa IVD Market, by Technology, 2021–2030 (USD Million)
Table 7 Africa IVD Market for Molecular Diagnostics, by Country/Region, 2021–2030 (USD Million)
Table 8 Africa IVD Market for Point-Of-Care Diagnostics, by Country/Region, 2021–2030 (USD Million)
Table 9 Africa IVD Market for Immunoassay/Immunochemistry, by Country/Region, 2021–2030 (USD Million)
Table 10 Africa IVD Market for Biochemistry/Clinical Chemistry, by Country/Region, 2021–2030 (USD Million)
Table 11 Africa IVD Market for Whole Blood Glucose Monitoring, by Country/Region, 2021–2030 (USD Million)
Table 12 Africa IVD Market for Hematology, by Country/Region, 2021–2030 (USD Million)
Table 13 Africa IVD Market for Microbiology, by Country/Region, 2021–2030 (USD Million)
Table 14 Africa IVD Market for Coagulation and Hemostasis, by Country/Region, 2021–2030 (USD Million)
Table 15 Africa IVD Market for Other IVD Technologies, by Country/Region, 2021–2030 (USD Million)
Table 16 Africa IVD Market, by Application, 2021–2030 (USD Million)
Table 17 COVID-19 Cases & Mortalities in Africa (As of June 2023)
Table 18 Africa IVD Market for Infectious Diseases, by Country/Region, 2021–2030 (USD Million)
Table 19 Africa: Cancer Burden, by Country, 2020 Vs. 2030
Table 20 Africa IVD Market for Oncology, by Country/Region, 2021–2030 (USD Million)
Table 21 Africa: Diabetes Cases, by Country (2021 Vs 2030)
Table 22 Africa IVD Market for Diabetes, by Country/Region, 2021–2030 (USD Million)
Table 23 Africa IVD Market for Cardiology, by Country/Region, 2021–2030 (USD Million)
Table 24 Africa IVD Market for Nephrology, by Country/Region, 2021–2030 (USD Million)
Table 25 Africa IVD Market for Autoimmune Disorders, by Country/Region, 2021–2030 (USD Million)
Table 26 Africa IVD Market for Other Applications, by Country/Region, 2021–2030 (USD Million)
Table 27 Africa IVD Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 28 Africa IVD Market for Laboratory Testing, by Country/Region, 2021–2030 (USD Million)
Table 29 Africa IVD Market for Point-Of-Care Testing, by Country/Region, 2021–2030 (USD Million)
Table 30 Africa IVD Market for OTC/Self-Testing, by Country/Region, 2021–2030 (USD Million)
Table 31 Africa In Vitro Diagnostics Market, by End User, 2021–2030 (USD Million)
Table 32 Africa In Vitro Diagnostics Market for Hospitals & Clinics, by Country/Region, 2021-2030 (USD Million)
Table 33 Africa In Vitro Diagnostics Market for Diagnostic Laboratories, by Country/Region, 2021-2030 (USD Million)
Table 34 Africa In Vitro Diagnostics Market for Home Healthcare, by Country/Region, 2021-2030 (USD Million)
Table 35 Africa In Vitro Diagnostics Market for Other End Users, by Country/Region, 2021-2030 (USD Million)
Table 36 Africa: HIV and AIDS Statistics (2021)
Table 37 Health Expenditure (% of GDP), 2018–2021
Table 38 Africa: Social and Economic Indicators, by Country
Table 39 Africa IVD Market, by Country/Region, 2021–2030 (USD Million)
Table 40 Africa IVD Market, by Product Category, 2021–2030 (USD Million)
Table 41 Africa IVD Market, by Technology, 2021–2030 (USD Million)
Table 42 Africa IVD Market, by Application, 2021–2030 (USD Million)
Table 43 Africa IVD Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 44 Africa IVD Market, by End User, 2021–2030 (USD Million)
Table 45 South Africa: IVD Market, by Product Category, 2021–2030 (USD Million)
Table 46 South Africa: IVD Market, by Technology, 2021–2030 (USD Million)
Table 47 South Africa: IVD Market, by Application, 2021–2030 (USD Million)
Table 48 South Africa: IVD Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 49 South Africa: IVD Market, by End User, 2021–2030 (USD Million)
Table 50 Egypt: IVD Market, by Product Category, 2021–2030 (USD Million)
Table 51 Egypt: IVD Market, by Technology, 2021–2030 (USD Million)
Table 52 Egypt: IVD Market, by Application, 2021–2030 (USD Million)
Table 53 Egypt: IVD Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 54 Egypt: IVD Market, by End User, 2021–2030 (USD Million)
Table 55 Algeria: IVD Market, by Product Category, 2021–2030 (USD Million)
Table 56 Algeria: IVD Market, by Technology, 2021–2030 (USD Million)
Table 57 Algeria: IVD Market, by Application, 2021–2030 (USD Million)
Table 58 Algeria: IVD Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 59 Algeria: IVD Market, by End User, 2021–2030 (USD Million)
Table 60 Nigeria: IVD Market, by Product Category, 2021–2030 (USD Million)
Table 61 Nigeria: IVD Market, by Technology, 2021–2030 (USD Million)
Table 62 Nigeria: IVD Market, by Application, 2021–2030 (USD Million)
Table 63 Nigeria: IVD Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 64 Nigeria: IVD Market, by End User, 2021–2030 (USD Million)
Table 65 Morocco: IVD Market, by Product Category, 2021–2030 (USD Million)
Table 66 Morocco: IVD Market, by Technology, 2021–2030 (USD Million)
Table 67 Morocco: IVD Market, by Application, 2021–2030 (USD Million)
Table 68 Morocco: IVD Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 69 Morocco: IVD Market, by End User, 2021–2030 (USD Million)
Table 70 Kenya: IVD Market, by Product Category, 2021–2030 (USD Million)
Table 71 Kenya: IVD Market, by Technology, 2021–2030 (USD Million)
Table 72 Kenya: IVD Market, by Application, 2021–2030 (USD Million)
Table 73 Kenya: IVD Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 74 Kenya: IVD Market, by End User, 2021–2030 (USD Million)
Table 75 Tunisia: IVD Market, by Product Category, 2021–2030 (USD Million)
Table 76 Tunisia: IVD Market, by Technology, 2021–2030 (USD Million)
Table 77 Tunisia: IVD Market, by Application, 2021–2030 (USD Million)
Table 78 Tunisia: IVD Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 79 Tunisia: IVD Market, by End User, 2021–2030 (USD Million)
Table 80 Tanzania: IVD Market, by Product Category, 2021–2030 (USD Million)
Table 81 Tanzania: IVD Market, by Technology, 2021–2030 (USD Million)
Table 82 Tanzania: IVD Market, by Application, 2021–2030 (USD Million)
Table 83 Tanzania: IVD Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 84 Tanzania: IVD Market, by End User, 2021–2030 (USD Million)
Table 85 Prevalence of Diseases in the Rest of Africa Region
Table 86 Rest of Africa: IVD Market, by Product Category, 2021–2030 (USD Million)
Table 87 Rest of Africa: IVD Market, by Technology, 2021–2030 (USD Million)
Table 88 Rest of Africa: IVD Market, by Application, 2021–2030 (USD Million)
Table 89 Rest of Africa: IVD Market, by Diagnostic Approach, 2021–2030 (USD Million)
Table 90 Rest of Africa: IVD Market, by End User, 2021–2030 (USD Million)
Table 91 Recent Developments, by Company, 2020–2023
Table 92 Abbott Laboratories in Africa
Table 93 bioMérieux SA in Africa
Table 94 Company Subsidiaries and Associates in Africa
Table 95 Siemens Healthineers AG in Africa
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for this Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Africa IVD Market, by Product Category, 2023 Vs. 2030 (USD Million)
Figure 8 Africa IVD Market, by Technology, 2023 Vs. 2030 (USD Million)
Figure 9 Africa IVD Market, by Application, 2023 Vs. 2030 (USD Million)
Figure 10 Africa IVD Market, by Diagnostic Approach, 2023 Vs. 2030 (USD Million)
Figure 11 Africa IVD Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 12 Africa IVD Market, by Country/Region
Figure 13 Market Dynamics
Figure 14 Africa IVD Market, by Product Category, 2023 Vs. 2030 (USD Million)
Figure 15 Africa IVD Market, by Technology, 2023 Vs 2030 (USD Million)
Figure 16 Adult Population (20–79 Years) with Diabetes in African Countries (Millions)
Figure 17 Africa IVD Market, by Application, 2023 Vs 2030 (USD Million)
Figure 18 Number of HIV Cases Vs HIV/AIDS Deaths in African Countries (2020)
Figure 19 Africa IVD Market, by Diagnostic Approach, 2023 Vs 2030 (USD Million)
Figure 20 Africa In Vitro Diagnostics Market, by End User, 2023 Vs. 2030 (USD Million)
Figure 21 Africa: Number of People (Aged 20–79 Years) with Diabetes (In Millions), 2021–2045
Figure 22 Africa IVD Market, by Snapshot
Figure 23 South Africa: Number of People (All Ages) Living with HIV (2010–2020)
Figure 24 South Africa: Number of People with Diabetes (In Thousands), 2000–2045
Figure 25 Algeria: Population Aged 65 and Above (2015–2021)
Figure 26 Algeria: People Aged 20-79 Years Suffering from Diabetes (2011–2045) (In Thousand)
Figure 27 Nigeria: Number of Pmi-Supported Health Facilities (2016–2020)
Figure 28 Morocco: Number of New Cancer Cases: 2020-2030
Figure 29 Share of People Living in Urban Areas: 2015–2020
Figure 30 Public Expenditure On Healthcare as Percent of Total Healthcare Expenditure: 2015–2021
Figure 31 Tanzania: Number of People with HIV (2010–2020)
Figure 32 Tanzania: Number of Adults (20–79 Years) with Diabetes (2011–2021)
Figure 33 Key Growth Strategies Adopted by Leading Players (2020–2023)
Figure 34 Africa IVD Market: Competitive Benchmarking
Figure 35 Market Share Analysis: Africa IVD Industry (2022)
Figure 36 Abbott Laboratories: Financial Overview (2022)
Figure 37 Becton, Dickinson and Company: Financial Overview (2022)
Figure 38 bioMérieux SA: Financial Overview (2022)
Figure 39 Danaher Corporation: Financial Overview (2022)
Figure 40 F. Hoffmann-La Roche Ltd.: Financial Overview (2022)
Figure 41 QIAGEN N.V.: Financial Overview
Figure 42 Siemens Healthineers AG: Financial Overview (2022)
Figure 43 Thermo Fisher Scientific, Inc.: Financial Overview (2022)
Figure 44 Bio-Rad Laboratories, Inc.: Financial Overview (2022)
Figure 45 Illumina, Inc.: Financial Overview (2022)
Figure 46 Shenzhen Mindray Bio-Medical Electronics Co., Ltd: Financial Overview (2022)

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings